Bid outcomes
How their decided bids ended, by number and by valueWhere they win
3 authorities · 1 stateTop buyer organisations
Operating states
Top competitors
In tenders they both bid · bar shows how the awards splitRecent tenders awarded to Keps Pharma
- Tender for purchase of Group-2 Medicines for NMMC Hospitals (For Year 2025 - 2026 to 2026 - 2027)Navi Mumbai Municipal Corporation · Maharashtra · 17 Sept 2026₹9.3 L
- Tender for purchase of Group-3 Medicines for NMMC Hospitals (For Year 2025 - 2026 to 2026 - 2027)Navi Mumbai Municipal Corporation · Maharashtra · 17 Sept 2026₹7.1 L
- Tender for purchase of Group-1 Medicines for NMMC Hospitals (For Year 2025 - 2026 to 2026 - 2027)Navi Mumbai Municipal Corporation · Maharashtra · 16 Sept 2026₹61.5 L
- INSULIN NPH/ISOPHANE 40 IU/ML 10ML VIAL (Highly Purified bovine porcine isophane insulin-susp 40 i.u./ml NPH insulin or neutral protamine Hagedom) (Also known as Humalin N, Novolin N, Novolin NPH Iltelin II and isophane insulin) (10ML VIAL/AMP.)Municipal Corporation of Greater Mumbai · Maharashtra · 6 Jun 2026₹94
- Purchase Injections for NMC Hospitals and DispensarysNashik Municipal Corporation · Maharashtra · 6 Jan 2026₹1
About Keps Pharma
Keps Pharma appears as a bidder on 14 government tenders on record, from 4 buyer authorities in 1 state. Of its 14 decided bids, it was awarded 5 — a 35.7% win rate — worth ₹77.9 L in total. Its most recent award on record is from 3 Oct 2026.
Its largest buyer by awarded value is Navi Mumbai Municipal Corporation, at 100.0% of what it has won, out of 3 authorities that have awarded it work. Most of its awards come from Maharashtra. On priced bids, its median quote is the lowest (L1).
It most often bids against AUSTIN HEALTH CARE, VARDHAN DISTRIBUTORS and Jainam Pharma (India) Pvt. Ltd.. AUSTIN HEALTH CARE bid on 11 of the same tenders and won 6 of them; Keps Pharma won 4.